Future-Proof Compliance – How a Leading Pharmaceutical Company Mastered the IDMP Challenge

Faced with the 2026 EMA deadline and a fragmented data landscape, a global pharma leader partnered with Accurids to master the IDMP challenge. They achieved a 200% ROI, reduced manual work by 75%, and built a future-ready data foundation in under 12 months.

‍

The Challenge: Fragmented Data and the 2026 EMA Deadline

‍

‍The European Medicines Agency (EMA) requires all pharmaceutical companies to achieve full compliance with Product Management Service (PMS) and ISO IDMP (Identification of Medicinal Products) standards by 2026. For a leading global pharmaceutical corporation, this mandate presented a significant hurdle. The company's product data was fragmented across various systems, validation processes were largely manual, and interoperability between its core Regulatory Information Management (RIM) and PMS systems was insufficient.

‍

These inefficiencies created operational risks, potential delays in regulatory submissions, and an increased likelihood of non-compliance. To remain competitive and ensure future readiness, the company needed a proactive and scalable data transformation strategy.

‍

The Solution: A Scalable Approach to Regulatory Excellence

‍

To meet the demanding EMA PMS compliance requirements, the corporation implemented a structured and scalable solution in partnership with Accurids. The strategy combined three key elements: automated data quality assessments, AI-driven data field mapping, and centralized issue tracking. This approach significantly accelerated data harmonization and created a transparent operational framework.

‍

A clearly defined implementation blueprint ensured a fast and predictable rollout, minimizing business disruption while strengthening data governance and regulatory confidence. Through this systematic approach, a mandatory regulatory task was transformed into an enabler for long-term digital and operational excellence.

‍

The Results: ROI, Agility, and a Future-Ready Data Foundation

‍

The project's outcomes were both measurable and transformative for the organization. Key performance indicators include:

‍

• A 75% reduction in manual workload
• Cost savings of €2.9 million
• A 200% Return on Investment (ROI) within three years
• Achieved break-even in less than 12 months

‍

Beyond the financial impact, the project accelerated time-to-market for new products, strengthened cross-team collaboration, and led to significantly higher data quality and consistency throughout the company.

‍

Furthermore, the corporation established a future-ready data foundation. This now supports advanced analytics, AI-driven insights, and far greater agility to respond quickly and efficiently to future regulatory changes.